Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Immunic Inc.

Immunic Inc. reported $92.76M in Cash and Equivalent for its fiscal quarter ending in March of 2023.

Cash And Equivalent Change
BioMarin Pharmaceutical BMRN:US USD 580.07M 144.46M
Dynavax Technologies DVAX:US USD 174.35M 27.65M
Enanta Pharmaceuticals ENTA:US USD 73.18M 30.96M
Immunic Inc. VTL:US USD 92.76M 13.98M
Insmed INSM:US USD 968.91M 105.13M
Intercept Pharmaceuticals ICPT:US USD 61.4M 10.89M
Mirati Therapeutics MRTX:US USD 232.96M 50.74M
OraSure Technologies OSUR:US USD 90.19M 6.21M
Quidel QDEL:US USD 353.9M 61M
Regulus Therapeutics RGLS:US USD 30.31M 6.08M
Revance Therapeutics RVNC:US USD 136.68M 27.71M
Ultragenyx Pharmaceutical RARE:US USD 85.77M 47.18M
United Therapeutics UTHR:US USD 1.16B 202.3M